To receive daily emails from Breaking Christian News to your inbox CLICK HERE

With a desire to inhibit metastasis, Cornell biomedical engineers have found the natural switch between the body’s inflammatory response and how malignant breast cancer cells use the bloodstream to spread.

(Ithaca, NY)—With a desire to inhibit metastasis, Cornell biomedical engineers have found the natural switch between the body’s inflammatory response and how malignant breast cancer cells use the bloodstream to spread. (PLOS ONE, Jan. 23, 2013)

Pro-inflammatory signaling molecules in blood called cytokines constitute a “switch” that induces the mechanism by which breast cancer cells “roll” and adhere to the blood vessel surface. The cancer cells eventually stick to the vessel and infiltrate it.

The laboratory of Michael R. King, Cornell professor of biomedical engineering has developed a flow chamber that mimics an inflamed endothelium (the blood vessel wall) and has used this to investigate the metastatic cascade.

In understanding the adhesive behavior of a particularly metastatic cell line, King and Yue Geng, graduate student in the field of biomedical engineering, discovered unexpectedly that these cells were unable to interact with selectins (receptor sites on the endothelium) —a key step in the metastatic cascade. This mechanism is identical to how white blood cells infiltrate blood vessels to reach the site of inflammation.

Cancer has long been associated with inflammation—the body’s natural defense mechanism—and now the researchers have demonstrated a definitive link. They found that the presence of pro-inflammatory molecules—the cytokines IL-6 and TNF-alpha—the malignant, hormone therapy-resistant breast cancer cells used in the study to adhere to the endothelial wall, leading to metastasis.

Before the cancer has spread, tumor cells first encounter IL-6 and TNF-alpha in the primary tumor’s microenvironment. These cytokines induce proliferation and aggregation of cancer cells, triggering other cancer cells to secrete more cytokines, resulting in a positive feedback loop.

The bioengineers went on to design several different cell culture setups to culture cancer cells with human plasma, IL-6 and TNF-alpha to test their hypotheses that inflammatory molecules in blood may induce adhesion capability. All of them promoted breast cancer cell metastatic behavior.

To confirm the results, the scientists used more sophisticated, real-life 3-D tumor spheroids, which are more physiologically accurate. In fact, the spheroid tumor cells exhibited the most significant increase in the interaction between the cancer cells and the blood vessel. They also treated some of the samples with a known anti-inflammatory drug called Metformin, which blocks IL-6, and they found that these samples were not able to metastasize—further accentuating their results.

Improving cancer treatment to fight metastasis via the bloodstream will depend on undoing this roll-and-stick mechanism of cancer cells, Geng says. The Cornell research could form the basis for immunotherapies to block the ligand-selectin binding of cancer cells, by first counteracting the inflammatory cytokines that, it seems, set the whole process in motion.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Christian Artist Forrest Frank Says He Will No Longer Participate in Awards Shows, Shares 'Conviction' Behind Why

Dolly Parton's Sister Gives Update on Country Music Legend's Health: 'I Was Up All Night Praying'

Trump Approves Alaska's Ambler Road Project That Unlocks Access to Critical Minerals

Thanks Chuck! Schumer Shutdown Allows Republicans to Confirm 107 Trump Nominees

Amid Schumer's Shutdown, President Trump Gets 'Creative' in Keeping the Women, Infant and Children's Nutritional Program Going

Chicago Bans ICE from Public Areas after Withholding Police Backup from Battered ICE Agents

Governor Youngkin Signs Executive Order to Keep Males Out of Female Spaces in Virginia

Seattle Public Schools Caught Pushing Free Chest Binders, Tucking Underwear to Kids

5 Key Signs to Spot a Human Trafficking Victim

CDC's Major Change on COVID-19 Vax; Lets Individuals Decide, and Makes Chickenpox Vaccine Standalone

COVER-UP EXPOSED: Declassified Docs Reveal Then-VP Biden Suppressed Report on Family's Foreign Entanglements

Another Scandal Threatens to Shake up Virginia's Elections

Dems Back Virginia AG Candidate Despite 'Violent, Disgusting, Disqualifying' Texts about Killing Republicans, and Their Children

Pam Bondi Tears into Illinois' Dem Senator: 'I Wish You Loved Chicago as Much as You Hate President Trump'

White House Slams 'Sick' Chicago Mayor Brandon Johnson After His Latest Anti-ICE Move

Portland DA Drops Charges against Conservative Journalist Who Was Attacked by Antifa

Battered, Yet Strong: With Christian and US Support, Israelis Mark 2 Years Since October 7th Atrocities

Leftists Try to Shut Down Pro-Charlie Kirk Coffee Shop: 'But God is Good'

Dr. Jordan Peterson Was 'Near Death' Over the Summer

'Playing God': Shocking Research Turns Skin Cells into Human Eggs [Video]

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor